IDIOPATHIC INFLAMMATORY MYOSITIS (IIM)
Clinical trials for IDIOPATHIC INFLAMMATORY MYOSITIS (IIM) explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC INFLAMMATORY MYOSITIS (IIM) trials appear
Sign up with your email to follow new studies for IDIOPATHIC INFLAMMATORY MYOSITIS (IIM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cord stem cells aim to tame muscle disease and cut steroid use
Disease control Recruiting nowThis study tests whether stem cells from umbilical cord lining can safely improve symptoms and reduce steroid use in adults with dermatomyositis or polymyositis—diseases that cause muscle weakness and inflammation. Forty participants will receive three doses of the stem cells and…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOSITIS (IIM)
Phase: PHASE2, PHASE3 • Sponsor: Restem, LLC. • Aim: Disease control
Last updated May 26, 2026 07:56 UTC
-
Experimental immune reset: could FT819 tame lupus and other autoimmune diseases?
Disease control Recruiting nowThis early-stage study tests a new cell therapy called FT819 in people with moderate-to-severe autoimmune diseases like lupus, vasculitis, myositis, and scleroderma. The goal is to see if it is safe and can reduce disease activity by targeting faulty B-cells. About 244 participan…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOSITIS (IIM)
Phase: PHASE1 • Sponsor: Fate Therapeutics • Aim: Disease control
Last updated May 22, 2026 13:50 UTC